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ABSTRACT 
Objective: The aim of this study to determine the oral hairy leukoplakia manifestations related to CD4 counts in HIV/AIDS patients. 
Methods: A cross-sectional study was conducted among 30 patients with HIV/AIDS, who have oral hairy leukoplakia manifestations. Diagnosis of 
oral hairy leukoplakia (OHL) based on clinical features. CD4 cell counts were obtained from medical records of patients. 
Results: The result show that oral hairy leukoplakia related to CD4 cell counts in HIV/AIDS patients had CD4 count<100 cells/mm3 (13.3%) and 
CD4 counts>100 cells/mm3 (3.3 %). 
Conclusion: Oral hairy leukoplakia manifestations in HIV/AIDS patients correlated with low levels CD4 cell counts. 
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Oral hairy leukoplakia (OHL) is an oral mucosal lesion caused by Epstein 
Barr virus (EBV). This lesion is a hyperplasia disorder of mucocutaneous 
epithelial cell. Clinical manifestations of lesions usually asymptomatic, 
white, extended, unilateral or bilateral on the lateral of the tongue border 
and often hairy or corrugated appearance and can also be plaque-like 
lesion [1-3]. EBV is a human herpes virus associated with important 
diseases in humans, including mononucleosis syndrome, infectious, 
lymphoma malignant and nasopharyngeal carcinoma. The prevalence of 
serologic EBV is estimated about 95% in adult humans worldwide. 
Circulation of the latently infected B-lymphocyte is believed to be a 
persistent area of lifelong infection of EBV [4]. 
The prevalence of OHL in adults is 20%-25% and increases with 
decreasing CD4 cell count, whereas in children the prevalence is about 
2%-3%, OHL is more common of adults with HIV infection than in HIV-
infected children, the presence of OHL is a sign of severe 
immunosuppression [5]. In people with AIDS, decline in the ability of the 
immune system is closely related with the incidence of opportunistic 
infections [6]. Greenspan et al. first found OHL in a group of homosexual 
patients in San Francisco. OHL is found usually in patients with human 
immunodeficiency virus (HIV), although it may be reported in OHL 
patients with other immunosuppressive conditions, such as patients 
undergoing organ transplantation, patients with haematological 
malignancies, and in patients requiring systemic steroid therapy [7-9]. 
The results of observational studies indicate that OHL in HIV-
infected patients with CD4 cell counts below 200 cells/mm3 have 
rapid progression to AIDS. OHL is a disease with small morbidity and 
does not always include intervention. Therefore, the OHL lesions are 
benign, asymptomatic and potentially self-limiting. OHL when 
associated with HIV infection, often with highly active anti-retroviral 
therapy (HAART) can trigger healing of OHL with decreased viral 
load and an increase in CD4 cell count. In general, OHL clinical 
findings are sufficient to diagnose patients with HIV infection, which 
is a typical manifestation [10]. 
This study aims to determine the oral manifestation of hairy 
leukoplakia associated with CD4 cell count in HIV/AIDS patients. 
MATERIALS AND METHODS 
Material 
The analytical observational study with cross-sectional study was 
conducted at Infection Center of DR Wahidin Sudirohusodo Hospital, 
Makassar, South Sulawesi (Ethical clearance from Medical Research 
Ethics Committee of Hasanuddin University NO UH16050421) study 
sample of 30 HIV/AIDS patients. The inclusion criteria was 
HIV/AIDS patients with CD4 cell counts<350 cells/mm2 at DR 
Wahidin Sudirohusodo Hospital while exclusion criteria were 
HIV/AIDS patients who were unwilling to participate this research. 
The diagnosis of oral hairy leukoplakia is determined based on 
clinical features in the oral cavity. The research procedure included 
data collection on HIV/AIDS patients at DR Wahidin Sudirohusodo 
Hospital. The type of data is secondary data obtained from the 
medical record and primary data obtained directly from the sample. 
Data was obtained by looking at the medical records of CD4 cell 
counts of HIV/AIDS patients then examining the patient's oral cavity 
to see the manifestation of OHL in the form of unusual white lesions 
on the lateral border of the tongue. 
RESULTS AND DISCUSSION 
In this study, OHL was examined by the presence of oral hairy 
leukoplakia manifestations associated with CD4 cell counts of 
HIV/AIDS patients who complied the inclusion and exclusion criteria 
of 30 patients. The decrease in CD4 cell count with the development 
of OHL manifestation in HIV/AIDS patients in terms of age group, 
CD4 cells, which can be seen in the table below. 
 
Table 1: Distribution of respondents by age group on development research of hairy Leukoplakia 2016 
Age (Years) N % 
30-35 3 10.0 % 
36-40 1 3.3 % 
>50 1 3.3 % 
Total 30 16,6 % 
Source: Primary Data, table 1 shows that from 30 respondents, the highest percentage of respondents is in the 30-35 y age group, which is 10%. 
While the lowest percentage of respondents is in the age group 36-40 y 3.3% and>50 y of 3.3% 
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Table 2: Distribution of respondents by CD4 category in development research of hairy Leukoplakia year 2016 
CD4 category N % 
<=100 4 13.3 % 
>100 1 3.3 % 
Total 30 16.6 % 
Source: Primary Data, table 2 shows that of 30 respondents who had CD4 count<100 cells/mm3 l counted 4 peoples (13.3%) while those with CD4 
count>100 cells/mm3were 1 people (3.3%). 
 
Clinically, OHL is a white plaque with corrugated surfaces, painless, 
and not removable by scraping. Mortin et al. explained that it is 
called hairy leukoplakia because of its white colour, and corrugated 
or shaggy appearance of the lateral tongue seen in many cases. The 
histopathological characteristics are hyperkeratosis, epithelial 
hyperplasia [3]. 
Oral hairy leukoplakia (OHL) is the result of infection associated 
with the presence of Epstein Barr virus (EBV) and almost all are 
found in HIV-infected individuals. Therefore a study of oral hairy 
leukoplakia manifestations was associated with CD4 cell count in 
HIV/AIDS patients. In this study obtained a total of 30 samples. 
Primary and secondary data taken by examining the oral cavity and 
also by looking at the medical records of people with HIV/AIDS. 
Characteristics of samples were seen from the age, known that the 
OHL manifestation in people with HIV/AIDS occurred at the age 
ranged from 30-35 y 10.0%, and in the age group 36-40 y and over 50 
y 3.3%. This is consistent with the results of several studies suggesting 
that OHL is more common in HIV-infected adults than in HIV-infected 
children. The result of research by Innes (2014) conducted at Dr 
Kariadi Hospital Semarang on 42 HIV/AIDS patients in the group age 
30-39 y. This result is also accordance with previous research showing 
that the highest percentage of HIV/AIDS patients recorded in CVT 
clinic RSUD Arifin Achmad is age group 30-39 y amounted to 37 
people (42.04%) followed by age 20-29 y amounted to 26 people 
(55%). From the results of these studies, it can be seen that cases of 
HIV/AIDS occur in the productive age 20-49 y. In the productive age 
group, a person is more likely to engage in sexual activities and drug 
abuse that is a high risk of transmitting the virus.  
Based on CD4 cell count with hairy leukoplakia progression, this 
study found<100 cells/mm3 count in 4 people (13.3%) while CD4 
count>100 cells/mm3 counted in 1 person (3.3%). Ghate et al. 
showed that patients with CD4 cell count<200 cells/mm3 had a six-
fold susceptibility in the development of opportunistic infections 
compared with CD4 cell count>350 cells/mm3. The Center for 
Disease Control and Prevention classified HIV patients into 3 
categories based on CD4 cell counts: CD4>500 cells/mm3, 200-499 
cells/mm3 and<200 cells/mm3. The lower CD4 cell count is 
associated with more severe immunosuppression [11]. 
According to Greenspan et al. hairy leukoplakia is an unusual white 
lesion on the lateral border of tongue. Recent study indicating that 
this hairy leukoplakia is the result of opportunistic infections 
associated with the presence of Epstein Barr virus (EBV) and almost 
all found in individuals with HIV infection. OHL is caused by the 
autoinoculation of Epstein Barr virus (EBV) through saliva and is 
associated with immunosuppression caused by HIV infection. EBV 
that has infected the epithelium will persist latently and periodically. 
Previous Morris research supports that in hairy leukoplakia is found 
100% Epstein Barr virus (EBV) particles. Research has shown that 
EBV replication in tongue cells is found only in patients with severe 
immunosuppression [12]. 
Frimpong et al. studied 6 to 9 types of lesions present in HIV 
patients: candidiasis, periodontitis, hyperpigmentation, melatonic, 
gingivitis, xerostomia and hairy leukoplakia. This condition is closely 
related to the number of CD4 cells in the patient [12, 13]. The results 
showed the lowest number of CD4 cells found in HIV patients with 
hairy leukoplakia, where the CD4 cell count was 138.8 cells/mm3. 
CD4 count is used as a marker to identify the progression of HIV and 
stage of immune suppression. Decreasing of CD4 cell count means 
increasing stage of immunosuppression, allowing for an increasing 
Epstein Barr Virus (EBV) replication and resulting in hairy 
leukoplakia [12]. Observational studies of several authors suggest 
that OHL patients develop into AIDS in a short period of time. This 
emphasizes the importance of OHL as an early indicator of 
immunosuppression and the progression of AIDS.  
HAART administration may trigger a decrease in viral load and 
increase CD4, thus helping to significantly reduce the prevalence of 
OHL patients. Systemic antiviral therapy of herpes provides rapid 
recovery although recurrence can sometimes occur when therapy is 
stopped. The combination of HAART and systemic antiviral therapy 
give satisfactory results of therapy and prevention of recurrence [10].  
CONCLUSION 
Based on results about oral hairy leukoplakia manifestations 
associated with CD4 cell counts in HIV/AIDS patients it can be 
concluded that low CD4 cell counts are associated with presence of 
oral hairy leukoplakia manifestations.  
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